导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.65% | 980/1050 |
| 近一周 | -0.96% | 602/1103 |
| 近一月 | -3.19% | 228/1102 |
| 近一季 | 2.01% | 218/1094 |
| 近半年 | -17.95% | 982/1074 |
| 近一年 | -27.24% | 973/1020 |
| 近两年 | -1.68% | 894/926 |
| 近三年 | -23.48% | 786/834 |
| 成立以来 | 12.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.02% 908/1070 |
-16.66% 1042/1101 |
- - |
- - |
| 2025 | 4.72% 889/1065 |
9.25% 175/1014 |
4.11% 355/1038 |
0.43% 994/1050 |
-8.32% 839/1065 |
| 2024 | -5.35% 716/1011 |
-1.58% 404/960 |
-4.40% 597/983 |
9.10% 700/991 |
-7.79% 812/1011 |
| 2023 | -18.11% 624/952 |
1.15% 564/880 |
-10.19% 777/895 |
-7.10% 436/915 |
-2.97% 327/952 |
| 2022 | -36.06% 713/867 |
-25.92% 726/773 |
11.60% 204/806 |
-25.07% 799/845 |
3.21% 272/867 |
| 2021 | -2.67% 391/740 |
2.17% 85/580 |
4.37% 477/659 |
-14.73% 603/704 |
7.04% 146/740 |
| 2020 | 64.10% 171/554 |
13.01% 27/419 |
37.31% 45/466 |
7.51% 311/517 |
-1.64% 498/554 |
| 2019 | 63.36% 66/410 |
40.82% 54/1146 |
3.05% 112/1228 |
-0.41% 343/390 |
13.04% 94/410 |
| 2018 | - - |
- - |
3.12% 34/990 |
-4.46% 432/1000 |
-12.93% 726/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 中欧品质消费股票C VS. 东吴新产业精选股票A(580008) |